Antidote revenue was £1.51 m in FY, 2018
Founding Date | 2009 |
Antidote total Funding | $40.9 m |
Antidote latest funding size | $23 m |
Time since last funding | a year ago |
Antidote investors | Amadeus Capital Partners, Merck Global Health Innovation Fund, Smedvig Capital, Octopus Ventures, LBO France |
GBP | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|
Revenue | 2.2m | 2.4m | 2.2m | 1.5m |
Revenue growth, % | 8% | (11%) | ||
Cost of goods sold | 912.3k | 1.1m | 892.3k | 1.1m |
Gross profit | 1.3m | 1.3m | 1.3m | 447.6k |
Gross profit Margin, % | 59% | 53% | 59% | 30% |
Operating expense total | 3.8m | 4.9m | 6.2m | |
Depreciation and amortization | 39.1k | |||
EBITDA | (2.5m) | (3.6m) | (4.9m) | |
EBITDA margin, % | (110%) | (151%) | (229%) | |
EBIT | (2.5m) | (3.7m) | (5.0m) | (5.5m) |
EBIT margin, % | (110%) | (152%) | (231%) | (366%) |
Interest expense | ||||
Interest income | ||||
Pre tax profit | (2.5m) | (3.7m) | (5.0m) | (5.5m) |
Income tax expense | (218.5k) | (375.3k) | (396.4k) | (276.4k) |
Net Income | (2.2m) | (3.3m) | (4.6m) | (5.3m) |
GBP | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|---|
Cash | 284.3k | 1.9m | 147.5k | 1.3m | 2.3m | 6.1m | 1.0m |
Accounts Receivable | 73.1k | 211.4k | 504.2k | 647.1k | 967.5k | 509.6k | 268.6k |
Inventories | |||||||
Current Assets | 357.4k | 2.1m | 651.8k | 2.2m | 3.7m | 7.2m | 1.8m |
PP&E | 1.5k | 6.7k | 14.9k | 85.5k | 77.0k | 66.4k | 52.2k |
Total Assets | 388.1k | 2.1m | 666.7k | 2.4m | 3.9m | 7.4m | 2.0m |
Accounts Payable | 23.9k | 61.6k | 1.0m | 226.3k | 77.5k | 197.3k | 57.9k |
Short-term debt | |||||||
Current Liabilities | 23.9k | 61.6k | 1.0m | 442.1k | 638.8k | 641.4k | 479.3k |
Long-term debt | |||||||
Non-Current Liabilities | 54.0k | 132.5k | 90.7k | 48.9k | |||
Total Debt | |||||||
Total Liabilities | 23.9k | 61.6k | 1.0m | 496.0k | 771.4k | 732.2k | 528.2k |
Common Stock | 43.0k | 45.1k | 44.3k | 45.0k | 45.9k | 48.7k | 65.8k |
Retained Earnings | (730.6k) | (3.2m) | (5.4m) | (8.7m) | (13.3m) | (18.6m) | |
Total Equity | 364.2k | 2.1m | (363.4k) | 1.9m | 3.1m | 6.7m | 1.5m |
Financial Leverage | 1.1 x | 1 x | -1.8 x | 1.3 x | 1.2 x | 1.1 x | 1.4 x |
GBP | FY, 2015 | FY, 2016 | FY, 2017 |
---|---|---|---|
Net Income | (2.2m) | (3.3m) | (4.6m) |
GBP | FY, 2012 |
---|---|
Financial Leverage | 1.1 x |